Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 mg/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 mg/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 mg/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 mg/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection
RxNorm 1657769
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1657769 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 mg/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 mg/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 mg/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 mg/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.